FAKTOR OPTIONSSCHEIN - AMGEN | Market Closed - Boerse Frankfurt Warrants 11:10:24 10/05/2024 pm IST | ||
| 4.32 EUR | +2.13% |
|
| Current month | -52.11% | ||
| 1 month | -57.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 4.32 | +2.13% | 0 |
| 09/24/09 | 4.23 | -12.96% | 0 |
| 08/24/08 | 4.86 | -5.63% | 0 |
| 07/24/07 | 5.15 | +0.98% | 0 |
| 06/24/06 | 5.1 | +22.01% | 0 |
Real-time Boerse Frankfurt Warrants
Last update May 10, 2024 at 11:10 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | UBS |
| WKN | UM1XK2 |
| ISIN | DE000UM1XK22 |
| Date issued | 20/02/2024 |
| Strike | 391.1 $ |
| Maturity | Unlimited |
| Parity | 16.65 : 1 |
| Emission price | 8.37 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.79 € |
|---|---|
| Lowest since issue | 3.82 € |
| Spread | 0.15 € |
| Spread % | 3.29% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
313.8
USD
Spread / Average Target
+1.18%
- Stock Market
- Certificates
- Certificat
